These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 7635617)

  • 1. Single Amino Acid Polymorphisms in the
    Miranda-Miranda E; Cossío-Bayúgar R; Trejo-Castro L; Aguilar-Díaz H
    Pathogens; 2023 Oct; 12(10):. PubMed ID: 37887771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum subtraction as a complementary method for six resolution techniques resolving overlapping spectra; application to multicomponent veterinary formulation with greenness and whiteness assessment.
    Hagag MG; Hemdan AM; Nadim AH; Abbas SS; Fahmy NM
    BMC Chem; 2023 Aug; 17(1):98. PubMed ID: 37582756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of sequestration of triclabendazole and associated metabolites by extracellular vesicles of Fasciola hepatica.
    Davis CN; Winters A; Milic I; Devitt A; Cookson A; Brophy PM; Morphew RM
    Sci Rep; 2020 Aug; 10(1):13445. PubMed ID: 32778698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: Compounds and therapeutic targets.
    Siles-Lucas M; Casulli A; Cirilli R; Carmena D
    PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006422. PubMed ID: 29677189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleiotropic alterations in gene expression in Latin American Fasciola hepatica isolates with different susceptibility to drugs.
    Radio S; Fontenla S; Solana V; Matos Salim AC; Araújo FMG; Ortiz P; Hoban C; Miranda E; Gayo V; Pais FS; Solana H; Oliveira G; Smircich P; Tort JF
    Parasit Vectors; 2018 Jan; 11(1):56. PubMed ID: 29368659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison between the Effects of Albendazole and Mebendazole on the Enzymatic Activity of Excretory / Secretory Products of Echinococcus granulosus Protoscoleces in Vitro.
    Adnani Sadati SJ; Farahnak A; Molaei Rad MB; Golestani A; Eshraghiyan MR
    Iran J Public Health; 2016 Feb; 45(2):223-9. PubMed ID: 27114987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triclabendazole Effect on Protease Enzyme Activity in the Excretory- Secretory Products of Fasciola hepatica in Vitro.
    Shrifi Y; Farahnak A; Golestani A; Eshraghian MR; Faridi A; Molaei Rad MB
    Iran J Parasitol; 2014 Mar; 9(1):107-13. PubMed ID: 25642266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro.
    Walker SM; McKinstry B; Boray JC; Brennan GP; Trudgett A; Hoey EM; Fletcher H; Fairweather I
    Parasitol Res; 2004 Dec; 94(6):427-38. PubMed ID: 15517388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.
    Robinson MW; Lawson J; Trudgett A; Hoey EM; Fairweather I
    Parasitol Res; 2004 Feb; 92(3):205-10. PubMed ID: 14652740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative proteomic analysis of triclabendazole response in the liver fluke Fasciola hepatica.
    Chemale G; Perally S; LaCourse EJ; Prescott MC; Jones LM; Ward D; Meaney M; Hoey E; Brennan GP; Fairweather I; Trudgett A; Brophy PM
    J Proteome Res; 2010 Oct; 9(10):4940-51. PubMed ID: 20726552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Threat of Triclabendazole Resistance in Fasciola hepatica.
    Kelley JM; Elliott TP; Beddoe T; Anderson G; Skuce P; Spithill TW
    Trends Parasitol; 2016 Jun; 32(6):458-469. PubMed ID: 27049013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasciola hepatica: Histology of the Reproductive Organs and Differential Effects of Triclabendazole on Drug-Sensitive and Drug-Resistant Fluke Isolates and on Flukes from Selected Field Cases.
    Hanna R
    Pathogens; 2015 Jun; 4(3):431-56. PubMed ID: 26131614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of triclabendazole ("Fasinex") on protein synthesis by the liver fluke, Fasciola hepatica.
    Stitt AW; Fairweather I; Mackender RO
    Int J Parasitol; 1995 Apr; 25(4):421-9. PubMed ID: 7635617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the sulphoxide metabolite of triclabendazole ('Fasinex') on the tegument of mature and immature stages of the liver fluke, Fasciola hepatica.
    Stitt AW; Fairweather I
    Parasitology; 1994 Jun; 108 ( Pt 5)():555-67. PubMed ID: 8052511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex).
    Stitt AW; Fairweather I
    Parasitol Res; 1993; 79(7):529-36. PubMed ID: 8278333
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.